Cationic PEGylated polycaprolactone nanoparticles carrying post-operation docetaxel for glioma treatment

• Cem Varan and
• Erem Bilensoy

Beilstein J. Nanotechnol. 2017, 8, 1446–1456, doi:10.3762/bjnano.8.144

• Background: Brain tumors are the most common tumors among adolescents. Although some chemotherapeutics are known to be effective against brain tumors based on cell culture studies, the same effect is not observed in clinical trials. For this reason, the development of drug delivery systems is important to

• treat brain tumors and prevent tumor recurrence. The aim of this study was to develop core–shell polymeric nanoparticles with positive charge by employing a chitosan coating. Additionally, an implantable formulation for the chemotherapeutic nanoparticles was developed as a bioadhesive film to be applied

• at the tumor site following surgical operation for brain glioma treatment. To obtain positively charged, implantable nanoparticles, the effects of preparation technique, chitosan coating concentration and presence of surfactants were evaluated to obtain optimal nanoparticles with a diameter of less

Low uptake of silica nanoparticles in Caco-2 intestinal epithelial barriers

• Dong Ye,
• Mattia Bramini,
• Delyan R. Hristov,
• Sha Wan,
• Anna Salvati,
• Christoffer Åberg and
• Kenneth A. Dawson

Beilstein J. Nanotechnol. 2017, 8, 1396–1406, doi:10.3762/bjnano.8.141

• Dong Ye Mattia Bramini Delyan R. Hristov Sha Wan Anna Salvati Christoffer Aberg Kenneth A. Dawson Centre for BioNano Interactions, School of Chemistry and Chemical Biology, University College Dublin, Belfield, Dublin 4, Ireland present address: AbbVie Deutschland GmbH & Co KG, Brain Delivery at

• exposure routes, cellular barriers, such as the skin, the lung epithelium, the intestinal epithelium or the endothelium (including the blood-brain barrier), constitute one of the first sites of interactions of nanoparticles, whether intended as nanomedicines or not, with organisms. Thus in addressing the

• type of barrier, namely an in vitro model of the human endothelial blood brain barrier [14][15][51][52]. Thus, the low degree of uptake observed in the Caco-2 barrier may be a characteristic of this type of barrier and could be related to the more complex polarised nature of thicker epithelial layers

Nano- and microstructured materials for in vitro studies of the physiology of vascular cells

• Alexandra M. Greiner,
• Adria Sales,
• Hao Chen,
• Sarah A. Biela,
• Dieter Kaufmann and
• Ralf Kemkemer

Beilstein J. Nanotechnol. 2016, 7, 1620–1641, doi:10.3762/bjnano.7.155

• mechanical properties of a substrate. Depending on the tissue in which cells live, the stiffness of the ECM can strongly vary from very low stiffness (e.g., brain: ca. 0.1–3 kPa) to intermediate stiffness (e.g., muscle: ca. 8–17 kPa) to high stiffness (e.g., cartilage: ca. 25–40 kPa) even reaching values in

Multiwalled carbon nanotube hybrids as MRI contrast agents

• Nikodem Kuźnik and
• Mateusz M. Tomczyk

Beilstein J. Nanotechnol. 2016, 7, 1086–1103, doi:10.3762/bjnano.7.102

• their potential as CAs exclusively in one of the MRI modes (T1 or T2). Further requirements consisted in better biocompatibility with the targeting of tumor cells, coupling with stem cells as well as crossing the cell membrane and blood–brain barrier. Finally, involving CNT activity in other diagnostic

• that the majority of hybrids had been eliminated via the feces. On the contrary, Gd-DTPA-oMWCNT#Marangon was found to undergo renal clearance and no lung accumulation was observed [36]. The presence of MWCNT CA candidates has not yet been tested in the brain. However, they are known for their ability

• to penetrate the blood-brain barrier, particularly as a function of their diameter [68]. Magnetic resonance imaging The visual effect of the MRI CA candidate constitutes final verification which is most important for this technique. The quantitative results are provided in Table 3. The MWCNT hybrids

Improved biocompatibility and efficient labeling of neural stem cells with poly(L-lysine)-coated maghemite nanoparticles

• Igor M. Pongrac,
• Marina Dobrivojević,
• Lada Brkić Ahmed,
• Michal Babič,
• Miroslav Šlouf,
• Daniel Horák and
• Srećko Gajović

Beilstein J. Nanotechnol. 2016, 7, 926–936, doi:10.3762/bjnano.7.84

• Igor M. Pongrac Marina Dobrivojevic Lada Brkic Ahmed Michal Babic Miroslav Slouf Daniel Horak Srecko Gajovic Croatian Institute for Brain Research, University of Zagreb School of Medicine, Šalata 3, 10000 Zagreb, Croatia Institute of Macromolecular Chemistry, Academy of Sciences, Heyrovského Sq. 2

• an expected impact on the treatment of brain diseases for which there is no adequate treatment yet. Neural stem cells (NSCs) have a high self-renewal ability as well as the ability to differentiate into neurons, astrocytes and oligodendrocytes, three principal cell types of the central nervous system

• PLL-γ-Fe2O3 nanoparticles were better than commercially available dextran-coated nanomag®-D-spio nanoparticles in NSC labeling. NSCs have a great potency to regenerate the central nervous system, and are often used as cells of choice in brain applications [2][3]. Despite a prior positive experience of

Tight junction between endothelial cells: the interaction between nanoparticles and blood vessels

• Yue Zhang and
• Wan-Xi Yang

Beilstein J. Nanotechnol. 2016, 7, 675–684, doi:10.3762/bjnano.7.60

• , such as hormones. Blood is extensively circulated through those vessels and NPs in the blood may reside on the surface of vessels or go through some barriers, e.g., the blood–brain barrier [15], blood–gas barrier [16] and blood–testis barrier [17], and reach important organs which then may get

• threatened (brain [18][19], lung [20][21] and testis [22]). In order to reduce possible limitations to the application of NPs, a better understanding of the relationship between the blood vascular system and NPs is very important. Review What are the side effects of NPs? The general definition of NPs regards

• induce brain dysfunction and pathology [25] and in some cases have an impact on gene expression in neural cells [26]. CuO NPs reduce cell viability and also cause oxidative stress in human bronchial epithelial cells [27]. Interaction between NPs and blood circulatory system The circulatory system or

Unraveling the neurotoxicity of titanium dioxide nanoparticles: focusing on molecular mechanisms

• Bin Song,
• Yanli Zhang,
• Jia Liu,
• Xiaoli Feng,
• Ting Zhou and
• Longquan Shao

Beilstein J. Nanotechnol. 2016, 7, 645–654, doi:10.3762/bjnano.7.57

• and are widely used in many fields. Numerous in vivo studies, exposing experimental animals to these NPs through systematic administration, have suggested that TiO2 NPs can accumulate in the brain and induce brain dysfunction. Nevertheless, the exact mechanisms underlying the neurotoxicity of TiO2 NPs

• investigated comprehensively through studying every possible molecular mechanism. Keywords: autophagy; brain; DNA methylation; neurotoxicity; titanium dioxide nanoparticles; Introduction Titanium dioxide nanoparticles, smaller than 1 μm in at least one dimension, possess specific physico-chemical

• detected in the main organs of experimental animals [5][6] and in exhaled breath condensate of exposed workers [7]. This accumulation can in turn damage affected organs and induce dysfunction. The brain is of particular interest, as it is unable to regenerate from damage. Consequently, the neurotoxicity of

Surface coating affects behavior of metallic nanoparticles in a biological environment

• Darija Domazet Jurašin,
• Marija Ćurlin,
• Ivona Capjak,
• Tea Crnković,
• Marija Lovrić,
• Michal Babič,
• Daniel Horák,
• Ivana Vinković Vrček and
• Srećko Gajović

Beilstein J. Nanotechnol. 2016, 7, 246–262, doi:10.3762/bjnano.7.23

• Darija Domazet Jurasin Marija Curlin Ivona Capjak Tea Crnkovic Marija Lovric Michal Babic Daniel Horak Ivana Vinkovic Vrcek Srecko Gajovic Division of Physical Chemistry, Ruđer Bošković Institute, Bijenička cesta 54, 10 000 Zagreb, Croatia School of Medicine, Croatian Institute for Brain Research

Nanoinformatics for environmental health and biomedicine

• Rong Liu and
• Yoram Cohen

Beilstein J. Nanotechnol. 2015, 6, 2449–2451, doi:10.3762/bjnano.6.253

• for brain cancer [13]. As an imported aspect of nanoinformatics, recent advances in data mining/machine learning of nano-data are also reported in this Thematic Series. In one study, the toxicity of ZnO nanoparticles to zebrafish (measured by mortality rate (%)) was correlated to two principal

Ultrastructural changes in methicillin-resistant Staphylococcus aureus induced by positively charged silver nanoparticles

• Dulce G. Romero-Urbina,
• Humberto H. Lara,
• J. Jesús Velázquez-Salazar,
• M. Josefina Arellano-Jiménez,
• Eduardo Larios,
• Anand Srinivasan,
• Jose L. Lopez-Ribot and
• Miguel José Yacamán

Beilstein J. Nanotechnol. 2015, 6, 2396–2405, doi:10.3762/bjnano.6.246

• the size distribution histogram using Origin 2015. Culture preparation: The bacterial strains MSSA (UAMS1) and MRSA (TCH1516) were cultured at 37 °C for 24 h on selective plates (ChromAgar BD Biosciences). Stock cultures were stored at −80 °C in Brain Heart Infusion Agar or BHI (Difco) with 50

Analyzing collaboration networks and developmental patterns of nano-enabled drug delivery (NEDD) for brain cancer

• Ying Huang,
• Jing Ma,
• Alan L. Porter,
• Seokbeom Kwon and
• Donghua Zhu

Beilstein J. Nanotechnol. 2015, 6, 1666–1676, doi:10.3762/bjnano.6.169

• research come from a global compilation of research publication information on NEDD directed at brain cancer. We derive a family of indicators that address multiple facets of research collaboration and knowledge transfer patterns. Results show that: (1) international cooperation is increasing, but

• go well beyond journal impact factors. Results offer useful technical intelligence to help researchers identify potential collaborators and to help inform R&D management and science & innovation policy for such nanotechnologies. Keywords: bibliometrics; brain cancer; collaboration network; nano

• conjugates and so on [6][7][8]. Among these, the brain tumor-targeting drug delivery systems, which increase drug accumulation in the tumor region and reduce toxicity in the normal brain and peripheral tissue, are a promising new approach [9]. Collaboration fosters interactions between different actors

The eNanoMapper database for nanomaterial safety information

• Nina Jeliazkova,
• Charalampos Chomenidis,
• Philip Doganis,
• Bengt Fadeel,
• Roland Grafström,
• Barry Hardy,
• Janna Hastings,
• Markus Hegi,
• Vedrin Jeliazkov,
• Nikolay Kochev,
• Pekka Kohonen,
• Cristian R. Munteanu,
• Haralambos Sarimveis,
• Bart Smeets,
• Pantelis Sopasakis,
• Georgia Tsiliki,
• David Vorgrimmler and
• Egon Willighagen

Beilstein J. Nanotechnol. 2015, 6, 1609–1634, doi:10.3762/bjnano.6.165

• proposed to extend the list of endpoints for hazard identification to include cell uptake, cell viability, oxidative stress, inflammation, fibrosis, immunotoxicity, cardiovascular toxicity, ventilation rate, gill pathologies, mucus secretion and brain pathology. The EU guidance document lists the main

Influence of surface chemical properties on the toxicity of engineered zinc oxide nanoparticles to embryonic zebrafish

• Zitao Zhou,
• Jino Son,
• Bryan Harper,
• Zheng Zhou and
• Stacey Harper

Beilstein J. Nanotechnol. 2015, 6, 1568–1579, doi:10.3762/bjnano.6.160

• (SP), notochord (N), yolk sac edema (Y), axis (A), eye (E), snout (Sn), jaw (J), otic (O), heart (H), brain (B), somite (So), pectoral fin (PF), caudal fin (CF), pigment (P), circulation (C), trunk (T), swim bladder (SB), and touch response (TR). Statistical analysis Due to the non-parametric nature

• . The 19 sub-lethal endpoints are developmental progression (DP), spontaneous movement (SP), notochord (N), yolk sac edema (Y), axis (A), eye (E), snout (Sn), jaw (J), otic (O), heart (H), brain (B), somite (So), pectoral fin (PF), caudal fin (CF), pigment (P), circulation (C), trunk (T), swim bladder

• (SB), and touch response (TR). Supporting Information File 28: Fisher’s exact test p-value. The 19 sub-lethal endpoints are developmental progression (DP), spontaneous movement (SP), notochord (N), yolk sac edema (Y), axis (A), eye (E), snout (Sn), jaw (J), otic (O), heart (H), brain (B), somite (So

Tattoo ink nanoparticles in skin tissue and fibroblasts

• Colin A. Grant,
• Peter C. Twigg,
• Richard Baker and
• Desmond J. Tobin

Beilstein J. Nanotechnol. 2015, 6, 1183–1191, doi:10.3762/bjnano.6.120

• accumulation of micrometre- and nanometre-sized silver particles following subcutaneous injection in rats, and found that silver nanoparticles were distributed throughout the main organs especially kidney, liver, spleen, brain and lungs [31]. By contrast, the micrometre-sized silver particles did not get into

Influence of gold, silver and gold–silver alloy nanoparticles on germ cell function and embryo development

• Ulrike Taylor,
• Daniela Tiedemann,
• Christoph Rehbock,
• Wilfried A. Kues,
• Stephan Barcikowski and
• Detlef Rath

Beilstein J. Nanotechnol. 2015, 6, 651–664, doi:10.3762/bjnano.6.66

• gold and silver nanoparticles seems to be the liver followed by spleen and kidney [34][35]. But particles have also been localized in other organs including brain and testis, which represent sites particularly protected by the blood–brain and the blood–testis barrier [22][28][31][32][36][37]. An

Silica micro/nanospheres for theranostics: from bimodal MRI and fluorescent imaging probes to cancer therapy

• Shanka Walia and
• Amitabha Acharya

Beilstein J. Nanotechnol. 2015, 6, 546–558, doi:10.3762/bjnano.6.57

• nanocomposites which in turn confirmed the low cell toxicity level of the prepared nanocomposites. The biodistribution studies of such nanocomposites in mice showed that these were mainly located in lung, liver and spleen without any trace in the brain tissues. These results suggested that the prepared

• nanocomposites could not get through the blood brain barrier. The TEM and histopathological analysis of the liver tissues suggested these nanocomposites were mainly expelled out from the mice body possibly by liver secretion. In a similar way, Guo et al. [47] reported the synthesis of hybrid nanostructures of

• NPs. The best results were found for FITC-labeled γ-Fe2O3–SiO2-AP-CMCS NPs which showed a cell labeling of about 64%. Further these hybrid nanocomposites were injected into a rat brain to evaluate their applicability for MR imaging in vivo. The results suggested that the cell implant was visible as

Filling of carbon nanotubes and nanofibres

• Reece D. Gately and
• Marc in het Panhuis

Beilstein J. Nanotechnol. 2015, 6, 508–516, doi:10.3762/bjnano.6.53

• . The same article also discussed the potential use of SWCNTs for the treatment of central nervous system disorders due to their ability to pass through blood–brain barriers [50]. In this article, selected avenues for the filling of carbon nanotubes and nanofibres as well as applications of the filled

• , drug release, VGCNFs have not yet been evaluated. Whilst they have not demonstrated the same nanoscale interactions as CNTs (such as crossing the blood–brain barrier, which is still under investigation), they may have other applications on the larger scale and allow for higher drug storage capacity

Correction: Carbon-based smart nanomaterials in biomedicine and neuroengineering

• Antonina M. Monaco and
• Michele Giugliano

Beilstein J. Nanotechnol. 2015, 6, 499–499, doi:10.3762/bjnano.6.51

• Antonina M. Monaco Michele Giugliano Theoretical Neurobiology and Neuroengineering Lab, Department of Biomedical Sciences, University of Antwerp, Universiteitsplein 1, B-2610 Wilrijk, Belgium Brain Mind Institute, Swiss Federal Institute of Technology, Lausanne, CH-1015, Switzerland Department of

• should be: Acknowledgements We are grateful to Drs. C. Bittencourt, M. Prato, L. Ballerini, and M. Nesládek for discussions. We are also grateful to Drs. Henry Markram, Sébastien Lasserre, and the Blue Brain Project team at the EPFL for contributing the graphical abstract. Financial support from the

Overview about the localization of nanoparticles in tissue and cellular context by different imaging techniques

• Anja Ostrowski,
• Daniel Nordmeyer,
• Alexander Boreham,
• Cornelia Holzhausen,
• Lars Mundhenk,
• Christina Graf,
• Martina C. Meinke,
• Annika Vogt,
• Sabrina Hadam,
• Jürgen Lademann,
• Eckart Rühl,
• Ulrike Alexiev and
• Achim D. Gruber

Beilstein J. Nanotechnol. 2015, 6, 263–280, doi:10.3762/bjnano.6.25

• deposits in HE-stained sections of glioblastomas (Figure 1a), a common brain tumor with high clinical relevance [45]. Such particles have similarly been visualized after targeting prostate cancer cells in humans [46]. Iron oxide nanoparticles have been introduced as diagnostic tool or for the treatment of

Release behaviour and toxicity evaluation of levodopa from carboxylated single-walled carbon nanotubes

• Julia M. Tan,
• Jhi Biau Foo,
• Sharida Fakurazi and
• Mohd Zobir Hussein

Beilstein J. Nanotechnol. 2015, 6, 243–253, doi:10.3762/bjnano.6.23

• person diagnosed with PD shows typical motor symptoms such as resting tremor, spasticity, unstable posture, walking difficulty, dementia, slowness of body movements (bradykinesia) and involuntary movements (dyskinesia). This is due to depletion of dopamine (a catecholamine neurotransmitter) in the brain

• , due to its ability to cross the blood–brain barrier. However, responsive patients treated long term with LD therapy may experience a decrease in the duration of responsiveness to the treatment and side effects in motor fluctuation (dyskinesia) may result [13]. Moreover, once LD is administered orally

• into the body, the drug is immediately metabolized and only a small amount of drug reaches the central nervous system. To prevent LD from being rapidly metabolized before it reaches the brain, carbidopa, an inhibitor of dopamine decarboxylase, is commonly used in combination with LD to enhance the

Caveolin-1 and CDC42 mediated endocytosis of silica-coated iron oxide nanoparticles in HeLa cells

• Nils Bohmer and
• Andreas Jordan

Beilstein J. Nanotechnol. 2015, 6, 167–176, doi:10.3762/bjnano.6.16

• development of new therapies for numerous diseases. For example iron oxide nanoparticles are in clinical use already in the thermotherapy of brain cancer. Although it has been shown, that tumor cells take up these particles in vitro, little is known about the internalization routes. Understanding of the

Functionalization of α-synuclein fibrils

• Simona Povilonienė,
• Vida Časaitė,
• Virginijus Bukauskas,
• Arūnas Šetkus,
• Juozas Staniulis and
• Rolandas Meškys

Beilstein J. Nanotechnol. 2015, 6, 124–133, doi:10.3762/bjnano.6.12

• and non-neuronal cell lines, brain tissue and living human cells, and analyzed under non-denaturing conditions [49]. The purified protein was used to study the modification and fibrillization of α-SynC141. According to the literature, one of the main factors which induces fibrillization is low pH [50

Sequence-dependent electrical response of ssDNA-decorated carbon nanotube, field-effect transistors to dopamine

• Hari Krishna Salila Vijayalal Mohan,
• Jianing An and
• Lianxi Zheng

Beilstein J. Nanotechnol. 2014, 5, 2113–2121, doi:10.3762/bjnano.5.220

• sensors [1][2][3]. Of the numerous biomolecules, detection of dopamine (DA) is critical because of its high clinical importance in various brain functions such as learning, memory formation, message transfer in the central nervous system and understanding the pathological processes of Parkinson’s disease

PVP-coated, negatively charged silver nanoparticles: A multi-center study of their physicochemical characteristics, cell culture and in vivo experiments

• Sebastian Ahlberg,
• Alexandra Antonopulos,
• Jörg Diendorf,
• Ralf Dringen,
• Matthias Epple,
• Rebekka Flöck,
• Wolfgang Goedecke,
• Christina Graf,
• Nadine Haberl,
• Jens Helmlinger,
• Fabian Herzog,
• Frederike Heuer,
• Stephanie Hirn,
• Christian Johannes,
• Stefanie Kittler,
• Manfred Köller,
• Katrin Korn,
• Wolfgang G. Kreyling,
• Fritz Krombach,
• Jürgen Lademann,
• Kateryna Loza,
• Eva M. Luther,
• Marcelina Malissek,
• Martina C. Meinke,
• Daniel Nordmeyer,
• Anne Pailliart,
• Jörg Raabe,
• Fiorenza Rancan,
• Barbara Rothen-Rutishauser,
• Eckart Rühl,
• Carsten Schleh,
• Andreas Seibel,
• Christina Sengstock,
• Lennart Treuel,
• Annika Vogt,
• Katrin Weber and
• Reinhard Zellner

Beilstein J. Nanotechnol. 2014, 5, 1944–1965, doi:10.3762/bjnano.5.205

• brain astrocytes are shown to be fairly tolerant toward silver nanoparticles, silver nanoparticles induce the formation of DNA double-strand-breaks (DSB) and lead to chromosomal aberrations and sister-chromatid exchanges in Chinese hamster fibroblast cell lines (CHO9, K1, V79B). An exposure of rats to

• and/or intracellular dissolution of silver nanoparticles to silver ions. Silver nanoparticles and brain cells (astrocytes) Silver nanoparticles have been reported to damage the blood–brain barrier, to enter the brain and to cause neurotoxicity [96][97][98]. In addition, once nanoparticles have entered

• the brain, they are not efficiently cleared from the brain, in contrast to other organs, even during a long recovery period [99]. After crossing the blood–brain barrier into the brain, silver nanoparticles will immediately encounter astrocytes as these cells almost completely cover the brain

Carbon-based smart nanomaterials in biomedicine and neuroengineering

• Antonina M. Monaco and
• Michele Giugliano

Beilstein J. Nanotechnol. 2014, 5, 1849–1863, doi:10.3762/bjnano.5.196

• Antonina M. Monaco Michele Giugliano Theoretical Neurobiology and Neuroengineering Lab, Department of Biomedical Sciences, University of Antwerp, Universiteitsplein 1, B-2610 Wilrijk, Belgium Brain Mind Institute, Swiss Federal Institute of Technology, Lausanne, CH-1015, Switzerland Department of

• damaged brain functions is at the forefront of interdisciplinary research in materials science. Bioactive nanoparticles for drug delivery, substrates for nerve regeneration and active guidance, as well as supramolecular architectures mimicking the extracellular environment to reduce inflammatory responses

• in brain implants, are within reach thanks to the advancements in nanotechnology. In particular, carbon-based nanostructured materials, such as graphene, carbon nanotubes (CNTs) and nanodiamonds (NDs), have demonstrated to be highly promising materials for designing and fabricating nanoelectrodes and